PATENT CLAIM ANALYSIS

Application Number: 16164926
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "183000"]

Abstract:
The present invention relates to a pharmaceutical composition in the form of a storage-stable solution for the parenteral administration of ultrashort-effective β-adrenoreceptor antagonists, comprising a) an ultrashort-effective β-adrenoreceptor antagonist and/or a pharmaceutically acceptable salt thereof, b) water, and c) a cyclodextrin and/or a functional cyclodextrin derivative. The composition according to the invention has high stability, even without the presence of additional adjuvants.

Claim (Index 5):
The pharmaceutical composition of  claim 1 , wherein the concentration of the \u03b2-cyclodextrin or the functional cyclodextrin derivative is 0.4 to 5% (w/v).

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 1.51064
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14030692', '12529635', '13803712', '12613103', '10588070']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7359284014798585
- 35 USC 102 Novelty (BERT): 0.5032982945687012
- Combined Prediction Score: 0.7126653907887428
- Mean Citation Score: 210.657698
- Max Citation Score: 220.95491
- Similarity Product: 155.64262791800618

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test